Amass launched its new app update for AI and scientific research, featuring a rebuilt end-to-end app with eight connected scientific databases.
Published
Signal category
Products & Services
Quote
“The new Amass app is live! Our biggest app update yet to AI for scientific research.”
— Amass team
Company
Amass
A Scientific Intelligence Platform for Life Sciences - https://www.amass.tech
- Industry
- Software Development
- Location
- Copenhagen, DK
- Company size
- 9 employees
Amass is a scientific intelligence platform for R&D and business development teams in biotech and pharma. We help teams evaluate scientific claims, map competitive landscapes, and make better decisions across pipelines and external opportunities. The platform analyzes publications, patents, clinical trials, regulatory data, and internal sources such as ELNs and company datasets to generate structured, evidence-based insights. Common use cases include: • Scientific due diligence • Pipeline and target evaluation • Competitive intelligence • Literature review and evidence synthesis Used by teams across pharma, biotech, and life science investors. Available as SaaS, API, and enterprise integrations into internal R&D workflows.
Founded 2022